Patents by Inventor Ankit Puri

Ankit Puri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENHANCED CHEMILUMINESCENT ENZYME-LINKED IMMUNOSORBENT ASSAY FOR DETECTION OF ANTIBODIES AGAINST BABESIA MICROTI
    Publication number: 20230266306
    Abstract: Identification of immunodominant Babesia microti antigens using genome-wide immunoscreening is described. Candidate antigens were screened against sera from patients with clinical babesiosis. Also described are diagnostic assays with high sensitivity and specificity for detecting B. microti-specific antibodies in patient samples using the identified immunodominant antigens.
    Type: Application
    Filed: March 21, 2023
    Publication date: August 24, 2023
    Applicant: The U.S.A., as represented by the Secretary, Department of Health and Human Services
    Inventors: Sanjai Kumar, Nitin Verma, Ankit Puri
  • Enhanced chemiluminescent enzyme-linked immunosorbent assay for detection of antibodies against
    Patent number: 11639930
    Abstract: Identification of immunodominant Babesia microti antigens using genome-wide immunoscreening is described. Candidate antigens were screened against sera from patients with clinical babesiosis. Also described are diagnostic assays with high sensitivity and specificity for detecting B. microti-specific antibodies in patient samples using the identified immunodominant antigens.
    Type: Grant
    Filed: November 1, 2018
    Date of Patent: May 2, 2023
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, Yale University
    Inventors: Sanjai Kumar, Nitin Verma, Ankit Puri, Peter J. Krause
  • ENHANCED CHEMILUMINESCENT ENZYME-LINKED IMMUNOSORBENT ASSAY FOR DETECTION OF ANTIBODIES AGAINST BABESIA MICROTI
    Publication number: 20210181190
    Abstract: Identification of immunodominant Babesia microti antigens using genome-wide immunoscreening is described. Candidate antigens were screened against sera from patients with clinical babesiosis. Also described are diagnostic assays with high sensitivity and specificity for detecting B. microti-specific antibodies in patient samples using the identified immunodominant antigens.
    Type: Application
    Filed: November 1, 2018
    Publication date: June 17, 2021
    Applicants: The U.S.A., as represented by the Secretary, Department of Health and Human Services, Yale University
    Inventors: Sanjai Kumar, Nitin Verma, Ankit Puri, Peter J. Krause